Loading...
A168330 logo

Naturalendo Tech Co., Ltd.KOSDAQ:A168330 Stock Report

Market Cap ₩70.1b
Share Price
₩2.22k
My Fair Value
n/a
1Y-59.6%
7D-6.3%
1D
Portfolio Value
View

Naturalendo Tech Co., Ltd.

KOSDAQ:A168330 Stock Report

Market Cap: ₩70.1b

Naturalendo Tech (A168330) Stock Overview

Engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. More details

A168330 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

A168330 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Naturalendo Tech Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Naturalendo Tech
Historical stock prices
Current Share Price₩2,220.00
52 Week High₩6,300.00
52 Week Low₩1,958.00
Beta0.35
1 Month Change-6.13%
3 Month Change-14.78%
1 Year Change-59.64%
3 Year Change-18.08%
5 Year Changen/a
Change since IPO-90.56%

Recent News & Updates

Analysis Article Dec 05

There's No Escaping Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Muted Revenues Despite A 36% Share Price Rise

Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) shares have had a really impressive month, gaining 36% after a shaky...
Analysis Article Nov 20

Would Naturalendo Tech (KOSDAQ:168330) Be Better Off With Less Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Recent updates

Analysis Article Dec 05

There's No Escaping Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Muted Revenues Despite A 36% Share Price Rise

Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) shares have had a really impressive month, gaining 36% after a shaky...
Analysis Article Nov 20

Would Naturalendo Tech (KOSDAQ:168330) Be Better Off With Less Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Jul 11

Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) 32% Dip In Price Shows Sentiment Is Matching Revenues

Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) shares have retraced a considerable 32% in the last month, reversing a...
Analysis Article May 20

Naturalendo Tech Co., Ltd. (KOSDAQ:168330) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Despite an already strong run, Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) shares have been powering on, with a gain...
Analysis Article Apr 03

Naturalendo Tech Co., Ltd.'s (KOSDAQ:168330) Price Is Right But Growth Is Lacking

You may think that with a price-to-sales (or "P/S") ratio of 2.3x Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) is...
Analysis Article Nov 13

Naturalendo Tech Co., Ltd. (KOSDAQ:168330) Looks Inexpensive But Perhaps Not Attractive Enough

With a price-to-sales (or "P/S") ratio of 1.9x Naturalendo Tech Co., Ltd. ( KOSDAQ:168330 ) may be sending very bullish...
Analysis Article Mar 26

Is Naturalendo Tech (KOSDAQ:168330) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

A168330KR BiotechsKR Market
7D-6.3%-9.2%-11.9%
1Y-59.6%3.5%149.7%

Return vs Industry: A168330 underperformed the KR Biotechs industry which returned 3.5% over the past year.

Return vs Market: A168330 underperformed the KR Market which returned 149.7% over the past year.

Price Volatility

Is A168330's price volatile compared to industry and market?
A168330 volatility
A168330 Average Weekly Movement11.8%
Biotechs Industry Average Movement10.6%
Market Average Movement8.6%
10% most volatile stocks in KR Market16.0%
10% least volatile stocks in KR Market4.4%

Stable Share Price: A168330 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A168330's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200181Hee-do Kimwww.naturalendo.co.kr

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a ultimate men’s prostate and urinary support; and Quercus acuta Thunb. fruit extract for preventing skin aging caused by ultraviolet rays.

Naturalendo Tech Co., Ltd. Fundamentals Summary

How do Naturalendo Tech's earnings and revenue compare to its market cap?
A168330 fundamental statistics
Market cap₩70.09b
Earnings (TTM)-₩2.30b
Revenue (TTM)₩21.69b
3.2x
P/S Ratio
-30.4x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A168330 income statement (TTM)
Revenue₩21.69b
Cost of Revenue₩11.94b
Gross Profit₩9.75b
Other Expenses₩12.06b
Earnings-₩2.30b

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-73.00
Gross Margin44.97%
Net Profit Margin-10.63%
Debt/Equity Ratio35.9%

How did A168330 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/11 19:04
End of Day Share Price 2026/06/11 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Naturalendo Tech Co., Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyuk Jin YoonEugene Investment & Securities Co Ltd.
Dong Ha KimKyobo Securities Co., Ltd
Gi KimLS Securities Co., Ltd.